WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016184591) COMPOSITION FOR RENAL PROTECTION IN RENAL TRANSPLANT RECIPIENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/184591    International Application No.:    PCT/EP2016/056247
Publication Date: 24.11.2016 International Filing Date: 22.03.2016
IPC:
A61K 31/202 (2006.01), A61P 41/00 (2006.01), A61P 43/00 (2006.01), A61K 45/06 (2006.01)
Applicants: OSLO UNIVERSITETSSYKEHUS HF [NO/NO]; Postboks 4950 0424 Nydalen-Oslo (NO).
CENTRAL DENMARK REGION [DK/DK]; Skottenborg 26 8800 Viborg (DK)
Inventors: SVENSSON, My Hanna Sofia; (NO).
EIDE, Ivar Anders; (NO).
JENSSEN, Trond; (NO).
HARTMANN, Anders; (NO).
VIGE, Runar; (NO)
Agent: GLOBAL IP ASSOCIATION; ZRX-C6 67056 Ludwigshafen (DE)
Priority Data:
20150638 20.05.2015 NO
20151287 29.09.2015 NO
Title (EN) COMPOSITION FOR RENAL PROTECTION IN RENAL TRANSPLANT RECIPIENTS
(FR) COMPOSITION DE PROTECTION RÉNALE CHEZ LES RECEVEURS D'UNE TRANSPLANTATION RÉNALE
Abstract: front page image
(EN)The present invention relates to a method of administering a composition comprising n-3 PUFAs to a patient who has received, or who is scheduled to receive, a renal transplant. Particularly, the invention provides a method to increase the level of n-3 PUFAs or to correct a deficiency of n-3 PUFAs in the patient's blood. Further, the invention provides a composition for use in the treatment or dietary management of a patient who has received, or who is scheduled to receive, a renal transplant, wherein the composition comprises n-3 PUFAs.
(FR)La présente invention concerne un procédé d'administration d'une composition comprenant de des n-3 PUFA à un patient qui a reçu, ou qui va recevoir, une transplantation rénale. En particulier, l'invention concerne un procédé d'augmentation du niveau de n-3 PUFA ou de correction d'une déficience en n-3 PUFA dans le sang du patient. En outre, l'invention concerne une composition destinée à être utilisée dans le traitement ou la prise en charge alimentaire d'un patient qui a reçu, ou qui va recevoir une transplantation rénale, la composition comprenant des n-3 PUFA.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)